Retinopathy in a multiple sclerosis patient undergoing interferon-therapy

Multiple Sclerosis

Volumn 13, Issue 7, 2007, Pages 939-940

  Saito, Hitomi ^a   Suzuki, Mariko ^a   Asakawa, Takehiro ^a   Kato, Satoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Interferon; Multiple sclerosis; Retinopathy; Type C hepatitis

Indexed keywords

INTERFERON BETA SERINE; BETA INTERFERON; BIOLOGICAL RESPONSE MODIFIER;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; EXUDATE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR HEMORRHAGE; LIMB WEAKNESS; MALE; MULTIPLE SCLEROSIS; NEUROGENIC BLADDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARESTHESIA; RETINOPATHY; VISUAL ACUITY; VISUAL FIELD; CHEMICALLY INDUCED DISORDER; OPHTHALMOSCOPY; RETINA DISEASE;

ADULT; BIOLOGICAL RESPONSE MODIFIERS; HUMANS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS; OPHTHALMOSCOPY; RETINAL DISEASES;

EID: 35848945903     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507077403     Document Type: Article

References (5)

1. Guyer DR, Tiedman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-356.
2. Sommer S, Sablon JC, Zaoui M, Rozot P and Mosni A. Interferon beta-1b retinopathy during a treatment for multiple sclerosis. J Fr Ophtalmol 2001; 24: 509-512.
3. Mallada-Frechin J, Abellan-Miralles I, Alfaro-Beltra ML, Medrano V, Munoz-Gil MB, Fernandex Izquierdo et al. Retinopathy secondary to treatment with interferon beta-1a in a patient with multiple sclerosis. Rev Neurol 2005; 40: 484-488.
4. Abe T, Ono T, Nakajima A, Satoh N, Koizumi T, Sakuragi S et al. Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn J Ophthalmol 1995; 39: 411-419.
5. Jain K, Lam WC, Waheeb S, Thai Q, Heathcote J. Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 2001; 85: 1171-1173.